Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis – Yes
Piehl, Fredrik, Hillert, JanLanguage:
english
Journal:
Multiple Sclerosis Journal
DOI:
10.1177/1352458518757930
Date:
February, 2018
File:
PDF, 59 KB
english, 2018